Additional file 1: of Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

Appendix 1. Methodological comparison of IPD meta-analysis and previous study-level analysis of agreement between MRI and pathologic tumor measurements post-NAC. Appendix 2. PRISMA flowchart. Appendix 3. Research protocol and data collection template. Appendix 4. MRI technical characteristics of studies included in the IPD analysis. Appendix 5. Bland Altman Plots for MRI (absolute and log transformed values). Appendix 6. Bland Altman Plots for US (absolute and log transformed values). Appendix 7. Bland Altman Plots for mammography (absolute and log transformed values). Appendix 8. Bland Altman Plots for clinical examination (absolute and log transformed values). Appendix 9. Pooled relative differences (%) (fixed effect unless noted) and limits of agreement for studies and patients comparing the respective tests. Appendix 10. Forest plots of MRI and comparator tests (relative mean differences with pathology). Appendix 11. Forest plots of MRI and comparator tests (absolute mean differences with pathology). Appendix 12. Forest plots of MRI by chemotherapy agent and HER2 status (absolute mean differences with pathology). (DOC 796 kb)